Loading ETF profile…
The iShares Health Innovation Active ETF, also known as "the Fund," endeavors to optimize overall financial gains. It achieves this by strategically allocating capital to groundbreaking and nascent businesses operating within the healthcare domain.
| Symbol | Name | Weight | Market Value |
|---|---|---|---|
| MRK | MERCK & CO INC | 5.91% | $655.18K |
| JNJ | JOHNSON & JOHNSON | 5.20% | $576.22K |
| GILD | GILEAD SCIENCES INC | 4.75% | $526.16K |
| EW | EDWARDS LIFESCIENCES CORP | 4.71% | $522.10K |
| — | BLK CSH FND TREASURY SL AGENCY | 4.06% | $450.00K |
| BIIB | BIOGEN INC | 3.78% | $419.18K |
| MRNA | MODERNA INC | 3.74% | $414.58K |
| TMO | THERMO FISHER SCIENTIFIC INC | 3.71% | $411.21K |
| CRL | CHARLES RIVER LABORATORIES INTERNA | 3.63% | $402.19K |
| DHR | DANAHER CORP | 3.61% | $400.40K |
| WAT | WATERS CORP | 3.44% | $381.78K |
| AMGN | AMGEN INC | 3.40% | $377.14K |
| MTD | METTLER TOLEDO INC | 3.11% | $344.92K |
| VRTX | VERTEX PHARMACEUTICALS INC | 3.11% | $344.76K |
| ILMN | ILLUMINA INC | 2.53% | $280.34K |
| TECH | BIO TECHNE CORP | 2.43% | $269.77K |
| BRKR | BRUKER CORP | 2.33% | $257.77K |
| NOVN.SW | NOVARTIS AG | 2.22% | $246.45K |
| DXCM | DEXCOM INC | 2.21% | $244.44K |
| NBIX | NEUROCRINE BIOSCIENCES INC | 2.18% | $241.91K |
| ABBV | ABBVIE INC | 2.12% | $234.98K |
| CYTK | CYTOKINETICS INC | 2.05% | $226.88K |
| ROP.SW | ROCHE PS PAR AG | 2.04% | $226.27K |
| UNH | UNITEDHEALTH GROUP INC | 1.78% | $197.74K |
| INCY | INCYTE CORP | 1.70% | $188.62K |